text:
67 Accountant jobs in Johor Bahru, MALAYSIA – Base Salary 6000 USD per Month
Global Finance Company Looking to Hire 67 Accountants for accountant jobs in Johor Bahru, MALAYSIA.
Base Salary 6000 USD per Month - Education Requirement: Bachelor's Degree in Accounting.
Accountant, jobs , Johor Bahru, MALAYSIA
Accountant jobs in Johor Bahru, MALAYSIA
Job Posting Title
67 Accountant jobs in Johor Bahru, MALAYSIA
Job description
Qualified person who is trained in bookkeeping and in preparation, auditing and analysis of accounts. Accountants prepare annual reports and financial statements for planning and decision making, and advise on tax laws and investment opportunities.
Base Salary
6000 USD per Month
Education Requirements
Bachelor's Degree in Accounting
Employment Type (e.g. full-time, part-time, contract, temporary, seasonal, internship).
Full Time
Estimated Salary
72000 USD per year
Experience Requirements
Proven working experience as a accountant of One Year or more
Hiring Organization
Global Finance Company
Incentive Compensation
2000 USD per Month
Job Benefits
- Very competitive compensation package inclusive of a generous benefits package
- 100% of healthcare premium costs covered by employer, dependents added at 50% of cost
- life insurance
- 401(k) plan with up to 6% match
- Voluntary Benefits (Supplemental Life, Accident, Short Term Disability, etc.)
- Generous time off program includes 22 holidays, sick leave and vacation
- Other great benefits (Flexible spending account, EAP, tuition reimbursement, etc.)
Job Location
Johor Bahru, MALAYSIA
Occupational Category
Financial auditors and accountants
Bachelor's Degree in Accounting
Most employers require a minimum of a bachelor's degree in accounting to work in an accountant or auditor position. While a bachelor's degree is the minimum requirement, some companies prefer accountants with a graduate degree education. State requirements for a Certified Public Accountant license or certification include a minimum of a bachelor's degree.
- Proven working experience as accountant or in a relevant field
- Thorough knowledge of accounting and corporate finance principles and procedures
- Excellent accounting software user
- Strong attention to detail and confidentiality
- Advanced degree in Accounting
- CPA or CMA preferred
Relevant Occupation
- accountant
- accountant-controller
- accountants supervisor
- accounting controller
- analyst-accountant
- assistant controller
- auditor-CA (chartered accountant)
- auditor-chartered accountant (CA)
- auditor - finance
- auditors supervisor
- audit unit head - taxation
- bank branch accountant
- bank reserves auditor
- bankruptcy trustee
- branch accountant, bank
- budget accountant
- CA (chartered accountant)
- CA (chartered accountant) student
- certified general accountant (CGA)
- certified management accountant (CMA)
- CGA (certified general accountant)
- chartered accountant (CA)
- chartered accountant (CA) student
- chief accountant
- claims accountant
- CMA (certified management accountant)
- computer audit specialist
- cost accountant
- cost accounting supervisor
- departmental accountant
- division controller - accounting
- field auditor - finances
- financial accountant
- financial auditor
- financial control officer
- general accountant
- income tax adjuster
- income tax adviser
- income tax consultant
- income tax expert
- income tax investigator
- income tax specialist
- industrial accountant
- industrial auditor
- intermediate accountant
- internal auditor
- internal auditor - finances
- internal auditors supervisor - finances
- internal audit project manager
- internal audit supervisor - finances
- machine processing accountant
- management accountant
- management accounting chief
- manufacturing accountant
- officer, financial control
- plant accountant
- plant controller
- production accountant
- project accountant
- property accountant
- public accountant
- public accountants chief
- public accountants supervisor
- reinsurance analyst
- rulings officer, taxation
- sales auditor - finances
- senior accounting analyst
- senior cost accountant
- senior intern auditor
- supervisor, accountants
- supervisor, auditors
- supervisor, cost accounting
- supervisor, internal audit - finances
- supervisor, internal auditors - finances
- supervisor, public accountants
- tax accountant
- tax adviser
- tax analyst
- taxation rulings officer
- tax auditor
- tax consultant
- tax evaluator
- tax examiner
- tax expert
- tax specialist
Provides financial information to management by researching and analyzing accounting data; preparing reports. Prepares asset, liability, and capital account entries by compiling and analyzing account information.
Job Responsibilities / Duties include but not limited to:
- Prepares asset, liability, and capital account entries by compiling and analyzing account information.
- Documents financial transactions by entering account information.
- Recommends financial actions by analyzing accounting options.
- Summarizes current financial status by collecting information; preparing balance sheet, profit and loss statement, and other reports.
- Substantiates financial transactions by auditing documents.
- Maintains accounting controls by preparing and recommending policies and procedures.
- Guides accounting clerical staff by coordinating activities and answering questions.
- Reconciles financial discrepancies by collecting and analyzing account information.
- Secures financial information by completing data base backups.
- Maintains financial security by following internal controls.
- Prepares payments by verifying documentation, and requesting disbursements.
- Answers accounting procedure questions by researching and interpreting accounting policy and regulations.
- Complies with federal, state, and local financial legal requirements by studying existing and new legislation, enforcing adherence to requirements, and advising management on needed actions.
- Prepares special financial reports by collecting, analyzing, and summarizing account information and trends.
- Maintains customer confidence and protects operations by keeping financial information confidential.
- Maintains professional and technical knowledge by attending educational workshops; reviewing professional publications; establishing personal networks; participating in professional societies.
- Accomplishes the result by performing the duty.
- Contributes to team effort by accomplishing related results as needed.
Salary Currency
Accounting, Corporate Finance, Reporting Skills, Attention to Detail, Deadline-Oriented, Reporting Research Results, SFAS Rules, Confidentiality, Time Management, Data Entry Management, General Math Skills.
Special Commitments
- The Accountant must be able to perform the duties of the job.
- One to two years of experience in accounting and/or real estate accounting.
- Basic analytical skills.
- Basic knowledge of tax basis financial reporting.
- Ability to operate computer system and effectively input and download pertinent information.
- Ability to use and gain sufficient knowledge of computer software currently utilized by the Company.
- Must have good Excel skills.
- Ability to effectively listen to co-workers and respond to their requests.
- Ability to understand and communicate in English, both verbally and written.
67 Accountant jobs in Johor Bahru, MALAYSIA
Valid Through
30 days
Work Hours (e.g. 1st shift, night shift, 9am-5pm).
9 am – 5pm
Main Entity of Page
67 Accountant jobs in Johor Bahru, MALAYSIA
Job description
Global Finance Company Looking to Hire 67 Accountants for accountant jobs in Johor Bahru, MALAYSIA.
Base Salary 6000 USD per Month - Education Requirement: Bachelor's Degree in Accounting.
Qualified person who is trained in bookkeeping and in preparation, auditing and analysis of accounts. Accountants prepare annual reports and financial statements for planning and decision making, and advise on tax laws and investment opportunities.
An accountant is a practitioner of accounting or accountancy, which is the measurement, disclosure or provision of assurance about financial information that helps managers, investors, tax authorities and others make decisions about allocating resource(s).
In many jurisdictions, professional accounting bodies maintain standards of practice and evaluations for professionals. Accountants who have demonstrated competency through their professional associations' certification exams are certified to use titles such as Chartered Accountant, Chartered Certified Accountant or Certified Public Accountant. Such professionals are granted certain responsibilities by statute, such as the ability to certify an organization's financial statements, and may be held liable for professional misconduct. Non-qualified accountants may be employed by a qualified accountant, or may work independently without statutory privileges and obligations.
Cahan & Sun used archival study to find out that accountants' personal characteristics may exert a very significant impact during the audit process and further influence audit fees and audit quality.
The Big Four auditors are the largest employers of accountants worldwide. However, most accountants are employed in commerce, industry and the public sector.
Job Reference number: MALAYSIA-1711- 001
Apply Today
Apply Now & Send Your CV on: email@example.com,
Please keep in mind that must write Job Reference number in your email as Subject.
Education requirements for accountants
Accountants audit, prepare and analyze financial records of businesses and individuals. They can work in accounting or business firms, in an accounting department or as a certified public accountant, who requires a license in all 50 states. According to the Bureau of Labor Statistics, accountants must be Certified Public Accountants to file a report with the Securities and Exchange Commission. Successful accountants have met the education requirements that include at least a bachelor's degree.
Bachelor of Accounting
Most employers require a minimum of a bachelor's degree in accounting to work in an accountant or auditor position. While a bachelor's degree is the minimum requirement, some companies prefer accountants with a postgraduate education. State requirements for a Certified Public Accountant license or certification include a minimum of a bachelor's degree.
Minimum undergraduate credits
Certified public accountants must meet the state education requirements to qualify for the uniform CPA exam. While the requirements include a bachelor's degree education, most states include a minimum of 150 semester hours in college courses to qualify for a license. Some students may complete additional courses beyond the bachelor's degree to meet state requirements, and colleges may offer combined bachelor's and master's degree programs to satisfy the state licensing board.
Accounting course requirements
State requirements for certified public accountants may include an educational program that includes specific courses. For example, the state of New Hampshire requires applicants for a license to complete at least 12 semester hours in accounting courses. The state of California requires applicants to complete a minimum of 24 semester hours in accounting in courses such as financial reports, audits, taxes, financial statements and external reports. Johor Bahru requires at least 33 semester hours in accounting courses that must include a minimum of one course each in tax, accounting and financial reporting, management accounting and auditing.
Business course requirements
In addition to accounting courses, states may require applicants for a license to complete business courses. New Hampshire requires at least 12 hours in non-business commercial courses. California requires a minimum of 24 semester units in business courses in subjects such as economics, finance, marketing, business administration, commercial law, statistics, and business administration. The state of Johor Bahru requires at least 36 hours in general business courses to qualify for a certified public accountant's license.
Work experience
Work experience can provide additional training and education for accountants. State accounting boards may require candidates for a license to complete a number of years under the supervision and direction of a certified and authorized public accountant. Some states require a combination of education and work experience to obtain a license. For example, in New Hampshire, candidates with a bachelor's degree must complete two years of full-time experience to meet state requirements, but those with a master's degree can qualify with one year of work experience. Johor Bahru requires one year of experience for applicants. Work experience must be in the practice of accounting services.
Continuing education
Accountants who complete the requirements to obtain an initial license as a certified public accountant must complete continuing education to maintain it. For example, Florida requires certified public accountants to complete a minimum of 48 hours in two years of continuing education in accounting and auditing to maintain the license. Florida requires at least 5 percent of the hours of continuing education to be in ethics for accounting.
Benefits of Becoming an Accountant
Hand checking receipt with calculator next to it Pursuing a career as an accountant might be one of the best ways of investing in your education. All too often, graduates have celebrated their milestone of completing their associates, bachelors, masters, and even Ph.Ds. without knowing whether or not the degree that they've worked so hard for will render a return on their investment.
The reality with pursing a post-secondary degree is that there are no guarantees that anyone will land a dream job that offers financial security. However, it has been proven time and time again that these chances can be increased with a college degree. What better way to do that than with an Accounting Degree from Florida National University (FNU)?
Obtaining a degree in accounting has its advantages. Here are few of them:
Accountants Have a Better Understanding of Finances
After years of studying the art of money, accountants have gained the type of knowledge most people would pay for. Earning an accounting degree at FNU offers students a wide array of knowledge within its field. In addition to accounting, the FNU curriculum also provides information in areas like micro and macroeconomics, business and tax law, corporate finance, spreadsheet analysis, banking and finance, entrepreneurial, management, and supervisory skills. All of these skills are applicable to any job profession. Any employer would greatly benefit from an employee who possesses any of these skill sets. Having these talents can also be applied toward life skills in general.
The Demand for Accountants
As aforementioned, there are no guarantees that anyone will land a job once they have earned their degree, but it is worth noting that the demand for accountants ranks high. Accounting is all about managing money! It is the driving force of our economy. Every business needs an accountant to handle its finances. So it is safe to assume that there ought to be a significant demand for accountants.
"Everyone needs accounting," stated Chris Frey, United Data Technology's Director of Finance. "The demand is always constant, spanning across all industries and sectors creating job security along with career longevity."
However, it is up to the graduate to find these job opportunities.
Opportunity for Advancement
With the right kind of networking connections, an entry-level accountant can increase his/her salary within a year's time. The field of accounting is wide, but precise. With a baseline of accounting skills and continued education, one has the option of obtaining a job as a Budget Analyst, Auditor, Controller, Tax Accountant, Payroll Clerk, CPA, and even a CFO. Additionally, coupling accounting skills with any other type of skill set will create an attractive resume.
Having general knowledge of accounting principles provides a good foundation toward advancing into higher positions. For positions like Cost Accounting and Financial Planning & Analysis, it is important to know how the numbers in the report got created. Because, these days, it is no longer acceptable to just present a pretty PowerPoint presentation with colorful number and charts.
"The finance sector is under pressure to become more strategic." Frey said. "Companies expect their accounting and finance department to analyze, explain, and take action."
To know the actions that can be taken upon the results delivered, develop a plan to implement those actions, and change the future outcome, requires the skill set of an accountant.
The Pay Range for Accountants is Often Generous
Because of the nature of the profession, accountants typically begin their careers at a generous salary. The Bureau of Labor Statistics reported that the median salary for accountants in 2014 was $65,940 or $31.70 an hour. The lowest was $40,670 while the highest was allotted at approximately $115,950. These numbers vary depending on one's regional location, whether the company is privately owned, public, or operated by the government. It is also likely that the higher paid salaries are offered in bigger metropolitan areas.
The Ability to Start Your Own Business
It is not uncommon for some professionals to become entrepreneurs. This is sometimes done after years of on-the-job experience when an accountant has developed a sufficient amount of contacts. One may feel more comfortable after years of networking to use the contacts that they've developed to start their own business. Whether it's consulting or specializing in taxes, the options are endless when it comes to financial affairs.
Forbes announced an accountant as one of the best jobs in 2013. This is most likely because it's the type of profession that can stand on its own. Even as a self-employed accountant, one has the potential to earn a great deal of income just because of the demand of money management.
Have a Better Understanding of Tax Laws
A good education that is worth its salt will see to it that their accounting program will include a course on tax law. Because of the personal, legal, and business repercussions of breaking or neglecting any tax law, a professional who calls themselves an accountant must acquire some type of knowledge when it comes to taxes. Paying taxes are a requirement enforced by law for citizens to follow. Not knowing them does not relinquish a person from these responsibilities either. So getting an education that teaches these laws is most beneficial.


text:
Department of Health and Human Services
Participating Organizations
National Institutes of Health (NIH), (http://www.nih.gov)
Components of Participating Organizations
National Human Genome Research Institute (NHGRI), (http://www.nhgri.nih.gov)
Title: 1000 Genomes Project Dataset Analysis (U01)
Announcement Type
Request For Applications (RFA) Number: RFA-HG-09-002
Catalog of Federal Domestic Assistance Number(s)
Key Dates
Release Date: November 4, 2008
Letters of Intent Receipt Date: May 26, 2009
Application Receipt Date: June 26, 2009
Peer Review Dates: October-November 2009
Council Review Date: January 2010
Earliest Anticipated Start Date: April 2010
Additional Information To Be Available Date (Url Activation Date): April 2, 2009
Expiration Date: June 27, 2009
Due Dates
for E.O. 12372
Not Applicable
Overview Content
Executive Summary
Table of Contents
Part I
Overview Information
Part II Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
Section II. Award Information
1. Mechanism(s) of Support
2. Funds Available
Section III. Eligibility Information
1. Eligible Applicants
A. Eligible Institutions
B. Eligible Individuals
2.Cost Sharing or Matching
3. Other - Special Eligibility Criteria
Section IV. Application and Submission Information
1. Address to Request Application Information
2. Content and Form of Application Submission
3. Submission Dates and Times
A. Receipt, Review and Anticipated Start Dates
1. Letter of Intent
B. Sending an Application to the NIH
C. Application Processing
D. Application Assignment
4. Intergovernmental Review
5. Funding Restrictions
6. Other Submission Requirements and Information
Section V. Application Review Information
1. Criteria
2. Review and Selection Process
A. Additional Review Criteria
B. Additional Review Considerations
C. Resource Sharing Plan(s)
3. Anticipated Announcement and Award Dates
Section VI. Award Administration Information
1. Award Notices
2. Administrative and National Policy Requirements
A. Cooperative Agreement Terms and Conditions of Award
1. Principal Investigator Rights and Responsibilities
2. NIH Responsibilities
3. Collaborative Responsibilities
4. Arbitration Process
3. Reporting
Section VII. Agency Contact(s)
1. Scientific/Research Contact(s)
2. Peer Review Contact(s)
3. Financial/ Grants Management Contact(s)
Section VIII. Other Information - Required Federal Citations
Part II - Full Text of Announcement
Section I. Funding Opportunity Description
1. Research Objectives
In the last two years, genome-wide association (GWA) studies have been successful in finding hundreds of variants that are associated with diseases or other traits. These discoveries became possible because of the availability of a large catalog of single nucleotide polymorphisms (SNPs) across the human genome and the development of dense genotyping microarrays. These arrays are based on data from the International HapMap Project that show the pattern of variation across the genome. The arrays allow genotyping to be done in case and control samples at sufficient resolution to find regions of the genome that are associated with particular diseases or other traits.
This approach can provide only a general genomic location for the actual disease-causing or risk-elevating variants. The arrays type only a fraction of the variants found in the genome, because the HapMap data consist mostly of variants with a frequency of at least 5%. However, many other variants, both SNP and structural, also occur in any genomic region, and variants with lower frequencies also contribute to disease risk. Thus the initial follow-up to a GWA study finding that a region is associated with a disease or other trait is to try to discover all the other, untyped, variants in the region. Even then, it is usually not clear which genes and variants in the region causally contribute to the disease risk, because generally many variants in a region are statistically associated with each other. Thus, finding the full set of variants in the region is necessary, but determining which variants and genes cause the disease risk requires additional, functional studies to analyze their potential roles.
The international 1000 Genomes Project (www.1000genomes.org) is designed to support GWA studies by providing a public resource of almost all genetic variants across the human genome with a frequency of 1% or higher, and of genetic variants with even lower frequencies in gene regions. When the 1000 Genomes resource is available, investigators will not have to take the time and expense to follow up a GWA study by sequencing the regions of interest; they will be able to look in a public database and find an almost complete catalog of the variants in those regions, including almost all of the ones that functionally cause the increased disease risk.
The 1000 Genomes Project has developed rapidly since its adoption at an international meeting in September of 2007. It will be the first large-scale project to use the next-generation sequencing platforms for extensive human resequencing. The sequence data for the Project will be generated at the NHGRI-funded centers at the Baylor College of Medicine, the Broad Institute of MIT and Harvard, and Washington University in St. Louis, as well as centers at the Wellcome Trust Sanger Institute, the Beijing Genomics Institute Shenzhen, the Max Planck Institute for Molecular Genetics, Applied Biosystems, Illumina, and Roche.
The strategy initially proposed for the 1000 Genomes Project is to sequence the genomes of 1200-1500 individuals to a depth of coverage of at least 4X (haploid equivalents) across the genome and 12X in gene regions. To test the value of this approach and to address several other issues related to the design of the full-scale effort, the Project has begun with three pilot projects. Sequence data production for the pilot projects started in January 2008 and should be finished early in 2009. The data from these pilots will be analyzed, and the design for the full-scale project will be developed by early 2009. Sequencing for the full-scale project should start in the fall of 2008 and continue for about two years, through about the end of 2010. The entire sequence dataset is anticipated to be at least 20 Terabases, a massive amount of data.
The 1000 Genomes Project dataset has been identified as a community resource, as described in the proceedings of the Meeting on Sharing Data from Large-Scale Biological Research Projects (http://www.wellcome.ac.uk/doc_wtd003208.html). The Project plans to release the raw sequence data and many processed data types publicly, quickly, and on a regular basis. The sequencing centers already send the raw sequence reads regularly to the Project's Data Coordination Center (DCC), provided jointly by the European Bioinformatics Institute (EBI) and the National Center for Biotechnology Information (NCBI) of NIH, which quickly deposits them in the public Short-Read Archive database.
Because the next-generation sequencing platforms are in an early stage for production use, a number of analytical methods are still being developed to use the raw sequence reads to produce the derived data types that most users will need. Some of these methods, such as generating data quality scores, will apply to many types of sequencing projects. Others, such as combining data across samples, will be more specific to the 1000 Genomes Project. Data-processing pipelines are currently being developed that will allow the DCC to use the sequence reads to provide several derived data types, such as read alignments, SNPs and structural variants, and genotypes of individual samples, along with their quality measures. When the Project has produced the full 1000 Genomes dataset, many other types of analyses will be needed to characterize it and make it more useful for the research community. The Project plans to release publicly the software that will be used to produce the various data types and analyze the dataset.
All of the data analysis activities for the 1000 Genomes Project are being coordinated through the Project's Production, Analysis, and Data Processing Groups, working with the DCC. Some of the participating research groups have funding from NIH or elsewhere to work on specific analyses. Other critical analysis work, however, is as yet unfunded.
Objectives of This Research Program
This FOA and its companion FOA (RFA-HG-09-001) aim to address the analysis needs of the 1000 Genomes Project on two timescales:
1. The companion FOA (RFA-HG-09-001 "1000 Genomes Project Data Processing") solicits proposals to perform the analyses needed to produce the 1000 Genomes dataset. It calls for proposals to carry out the analysis work needed to process the primary sequence data to produce the full derived Project dataset.
The companion FOA solicits proposals to continue to develop, evaluate, and implement the methods needed to produce the derived data types from the sequence data, monitor the quality of the data, integrate the data types, develop the tools needed to work with the data, and develop new processes as needed to produce the full derived Project dataset.
Because of the timing of the companion FOA, the initial software pipelines for the DCC to process the data will already have been set up when the awards are made. The two-year award period (July 2009 to June 2011) should allow for the development and implementation of the processes needed to produce the several derived data types on a regular basis. The sequencing is anticipated to be finished before these awards end, so that the full derived dataset can be produced using the entire set of Project sequence data.
2. This FOA (RFA-HG-09-002 "1000 Genomes Project Dataset Analysis"), in contrast, solicits proposals to analyze the full Project dataset, after it has been produced by work funded through the companion RFA-HG-09-001. This RFA-HG-09-002 calls for proposals to carry out the analysis work needed to maximize the value of the full 1000 Genomes Project dataset to the general research community
This FOA solicits proposals to characterize the dataset, provide additional derived data types, perform global analyses on the data, and develop better tools for using the dataset to study biomedical and biological research problems.
Because of the timing of this FOA, awardees will start to work with the dataset in about April 2010, before it is complete. This will allow them time to become familiar with the data, develop the methods using subsets of the data, and then be ready to analyze the full dataset when it becomes available, which is anticipated to be roughly in early 2011. Awardees will then have about a year to perform the analyses on the data. These awards are being made for only two years because it will be important to provide these characterizations, analyses, and tools rapidly so that the research community will be able to make full use of the 1000 Genomes resource as soon as possible.
Research Scope
Applicants for this FOA should propose to (a) develop the methods to characterize the full 1000 Genomes dataset; (b) develop the methods to provide derived datasets based on the 1000 Genomes dataset; (c) develop the methods to perform global analyses of the 1000 Genomes dataset; (d) evaluate the strategies that were used to develop the 1000 Genomes dataset; or (e) develop tools to allow the several 1000 Genomes data types to be used by researchers. Since the 1000 Genomes dataset is expected to support many types of studies, the proposed analyses should be broadly useful to the research community. They should also propose to develop the software to implement these methods, including documentation. Software developed by awardees should be modular, so that it can work as a stand-alone package. When possible, the software should use standard formats for data input and output, to facilitate its use and incorporation into central pipelines. These standard formats should be ones that the Project has already decided on, or, if new standard formats are needed, ones that the awardees develop in close collaboration with others in the Project Analysis Group and the DCC. The DCC is responsible for incorporating any software into its pipelines. Awardees will also be responsible for monitoring the Project data produced using their methods, and making adjustments to the methods as needed to correct problems or make improvements.
Although the DCC generally would be expected to run these analyses, the awardee might do so based on the types of analyses and the computing needs. If awardees run any analyses, they would generate Project datasets. As part of developing the analysis methods, awardees may also generate resource datasets that would be useful to others in the Project or more broadly, such as simulated datasets, test datasets, or annotated validation datasets. These datasets should be released publicly at the time that they are used to develop or analyze the main Project dataset.
Examples of research topics for this FOA include, but are not limited to, those listed below:
1. Analyze genomic coverage. Methods will need to be developed to provide the depth of sequence coverage across the genome and in gene regions, and to assess how the depth affects the data quality. The methods may incorporate random and systematic biases, which will produce different types of errors.
2. Analyze the frequency distribution of variants. A major goal of the Project is to find rare variants, so methods will need to be developed to examine the frequency distributions of various types of variants genome-wide and in gene regions.
3. Analyze haplotypes and the value of combining data across samples. Combining data across samples is a major analysis strategy of the Project for finding variants and inferring haplotypes. Although haplotypes are expected to be produced as part of the derived Project dataset, additional methods for analyzing the haplotypes will need to be developed, and it will be important to assess how well this strategy of combining data works.
4. Analyze special regions. Regions such as HLA, which have extensive sequence diversity and structural variation, will require the development of methods tailored to their characteristics. Note that the goal remains to characterize the entire 1000 Genomes resource, not to study particular regions because of biological or medical interest.
5. Analyze Imputed variants. Another major goal of the Project is to impute variants so that GWA studies can use those data for association analyses. Although imputed variants are expected to be produced as part of the derived Project dataset, additional methods for analyzing the imputed data will need to be developed, including examining how well variants of different types and frequencies can be imputed genome-wide and in gene regions.
6. Produce additional data types. The derived Project dataset will have the basic data types needed by the community, but genome-wide methods need to be developed to provide additional useful data types from the sequence data, the initial derived data types, or these data types in combination with additional data types. The additional data types could include the sequence or sequence variability in other species or expression data.
7. Compare populations. The populations to be studied in the Project are expected to have some differences in allele frequencies, the amount of variation, and LD patterns. Methods need to be developed to compare populations, evaluate admixture, and assess the value of the Project strategy of using sets of related populations to provide additional information on rare alleles.
8. Look for signals of natural selection. Methods need to be developed to study this large Project dataset, with many individuals and several populations, for various types of signals of natural selection.
9. Consider how the resource should be improved. By the time the Project dataset is produced, several studies of sequencing for follow-up to GWA studies should have been analyzed. It will be useful to develop methods to assess how well the data from the 1000 Genomes Project meet the needs of this follow-up for finding almost all variants in regions found to be associated with disease, and what additional data will be needed.
10. Develop tools for accessible analyses of the data for GWA and other studies. The Project will produce a massive dataset; maximizing its value to the scientific community will require the development of many tools to filter, visualize, and examine the data.
As much as possible, these analyses should be performed across the entire genome or in the entire set of gene regions, using all the samples. This FOA will not support the use of 1000 Genomes data for the analysis of the genetics of specific human diseases or other phenotypes.
See Section VIII, Other Information - Required Federal
Citations, for policies related to this announcement.
Section II. Award Information
1. Mechanism of Support
This FOA uses "Just-in-Time" information concepts. It also uses non-modular budget formats described in the PHS 398 application instructions (see https://grants.nih.gov/grants/funding/phs398/phs398.html).
This funding opportunity will use a cooperative agreement award mechanism. In the cooperative agreement mechanism, the Project Director/Principal Investigator (PD/PI) retains the primary responsibility and dominant role for planning, directing, and executing the proposed project, with NIH staff being substantially involved as a partner with the Principal Investigator, as described under the Section VI. 2. Administrative Requirements, "Cooperative Agreement Terms and Conditions of Award".
Plans beyond the current funding opportunity are indefinite.
2. Funds Available
Because the nature
and scope of the proposed research will vary from application to application,
it is anticipated that the size and duration of each award will also vary.
Although the financial plans of the IC(s) provide support for this program,
awards pursuant to this funding opportunity are contingent upon the
availability of funds and the receipt of a sufficient number of meritorious
Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation, see NOT-OD-05-004.
grants policies as described in the NIH
Grants Policy Statement.
3. Other-Special Eligibility Criteria
Applicants are not permitted to submit a resubmission application in response to this FOA.
Renewal applications are not permitted in response to this FOA.
Applicants may submit more than one application, provided each application is scientifically distinct.
Section IV. Application and Submission Information
Address to Request Application Information
The PHS 398 application instructions are available at https://grants.nih.gov/grants/funding/phs398/phs398.html in an interactive format. Applicants must use the currently approved version of the PHS 398. For further assistance contact GrantsInfo, Telephone (301) 710-0267, Email: firstname.lastname@example.com.
Telecommunications for the hearing impaired: TTY 301-451-5936.
2. Content and Form of Application Submission
Applications must be prepared using the most current PHS 398 research grant application instructions and forms. Applications must have a D&B Data Universal Numbering System (DUNS) number as the universal identifier when applying for Federal grants or cooperative agreements. The D&B number can be obtained by calling (866) 705-5711 or through the web site at http://www.dnb.com/us/. The D&B number should be entered on line 11 of the face page of the PHS 398 form.
The title and number of this funding opportunity must be typed in item (box) 2 only of the face page of the application form and the YES box must be checked.
Additional information is available in the PHS 398 grant application instructions.
Submission Dates and Times
Applications must be received on or before the receipt date described below (Section IV.3.A). Submission times N/A.
3.A. Receipt, Review and Anticipated Start Dates
Letters of Intent Receipt Date: May 26, 2009
Application Receipt Date: June 26, 2009
Peer Review Dates: October-November 2009
Council Review Date: January 2010
Earliest Anticipated Start Date:April 2010
Letter of Intent
Prospective applicants are asked to submit a letter of intent that includes the following information:
Although a letter of
intent is not required, is not binding, and does not enter into the review of a
subsequent application, the information that it contains allows IC staff to
estimate the potential review workload and plan the review.
The letter of intent is to be sent by the date listed in Section IV.3.A.
The letter of intent
should be sent to:
Lisa D. Brooks, Ph.D.
5635 Fishers Lane, Suite 4076
Bethesda, MD 20892-9305
(301) 435-5544
3.B. Sending an Application to the NIH
Applications must be prepared using the forms found in the PHS 398 instructions for preparing a research grant application. Submit a signed, typewritten original of the application, including the checklist, and three signed photocopies in one package to:
Center for Scientific Review
National Institutes of Health
6701 Rockledge Drive, Room 1040, MSC 7710
Bethesda, MD 20892-7710 (U.S. Postal Service Express or regular mail)
Bethesda, MD 20817 (for express/courier service; non-USPS service)
Personal deliveries
of applications are no longer permitted (see https://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-040.html).
At the time of submission, two additional copies of the application and all copies of the appendix material must be sent to:
Rudy Pozzatti, Ph.D.
NHGRI Review Branch
5635 Fishers Lane
Suite 4076, MSC 9306
Bethesda, MD 20892-9306
(For courier service use Rockville, MD 20852)
3.C. Application
Applications must be received on or before the application receipt date) described above (Section IV.3.A.). If an application is received after that date, the application may be delayed in the review process or not reviewed. Upon receipt, applications will be evaluated for completeness by the CSR and for responsiveness by the reviewing Institute Incomplete and/or non-responsive applications will not be reviewed.
The NIH will not accept any application in response to this funding opportunity that is essentially the same as one currently pending initial review, unless the applicant withdraws the pending application. However, when a previously unfunded application, originally submitted as an investigator-initiated application, is to be submitted in response to a funding opportunity, it is to be prepared as a NEW application. That is, the application for the funding opportunity must not include an Introduction describing the changes and improvements made, and the text must not be marked to indicate the changes from the previous unfunded version of the application.
Information on the status of an application should be checked by the Principal Investigator in the eRA Commons at: https://commons.era.nih.gov/commons/.
4. Intergovernmental Review
This initiative is not subject to intergovernmental
5. Funding Restrictions
All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The Grants Policy Statement can be found at NIH Grants Policy Statement.
Pre-award costs are allowable. A grantee may, at its
own risk and without NIH prior approval, incur obligations and expenditures to
cover costs up to 90 days before the beginning date of the initial budget
period of a new award if such costs: 1) are necessary to conduct the project,
and 2) would be allowable under the grant, if awarded, without NIH prior
approval. If specific expenditures would otherwise require prior approval, the
grantee must obtain NIH approval before incurring the cost. NIH prior approval
is required for any costs to be incurred more than 90 days before the beginning
date of the initial budget period of a new award.
The incurrence of pre-award costs in anticipation of a competing or non-competing award imposes no obligation on NIH either to make the award or to increase the amount of the approved budget if an award is made for less than the amount anticipated and is inadequate to cover the pre-award costs incurred. NIH expects the grantee to be fully aware that pre-award costs result in borrowing against future support and that such borrowing must not impair the grantee's ability to accomplish the project objectives in the approved time frame or in any way adversely affect the conduct of the project (see NIH Grants Policy Statement https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm.)
6. Other Submission Requirements and Information
Applicants should describe their expertise with analyses of 1000 Genomes data or similar data. They should describe how the proposed analyses would coordinate with analyses already being done by the Project. See www.1000genomes.org for a list of analyses being done by the Project, and for any additional information on this FOA.
Applicants should describe how they will develop the analyses and the software to run the analyses. They should describe the input and output data types and formats. They should explain how they will transfer the software to the DCC and work with the DCC to implement the analyses. Alternatively, if applicants propose that the DCC should not run a particular analysis centrally, they should justify why they or some other group should run that analysis, and explain how they would transfer the derived dataset to the DCC.
Applicants should describe any resource datasets (e.g., simulated data) that they would develop, and explain how they would disseminate them.
Applicants should describe the computing resources that are needed for the analyses and what resources they have available.
The Project has regular conference calls and meetings. Applicants should request funds over the two years to attend Project meetings once in the U.K., in May 2010 and May 2011 at the Cold Spring Harbor Laboratory, and prior to the 2010 and 2011 meetings of the American Society of Human Genetics.
Awardees must agree to the "Cooperative Agreement Terms and Conditions of Award" in Section VI.2.A "Award Administration Information".
Research Plan Page Limitations
The page limit is 25 pages for Items 2-5 of the Research Plan.
Appendix Materials
All paper PHS 398 applications submitted must provide appendix material on CDs only. Include five identical CDs in the same package with the application See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-031.html.
Do not use the Appendix to circumvent the page limitations of the Research Plan component. An application that does not observe the required page limitations may be delayed in the review process.Resource Sharing Plan(s)
NIH considers the sharing of unique research resources developed through NIH-sponsored research an important means to enhance the value of, and advance research. When resources have been developed with NIH funds and the associated research findings published or provided to NIH, it is important that they be made readily available for research purposes to qualified individuals within the scientific community. If the final data/resources are not amenable to sharing, this must be explained in Resource Sharing section of the application. See https://grants.nih.gov/grants/policy/data_sharing/data_sharing_faqs.htm.
(a) Data Sharing Plan: Regardless of the amount requested, investigators are expected to include a brief 1-paragraph description of how final research data will be shared, or explain why data-sharing is not possible. Applicants are encouraged to discuss data-sharing plans with their NIH program contact. See Data-Sharing Policy or https://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-032.html.
NHGRI has identified the 1000 Genomes Project as a community resource project. A primary objective of the 1000 Genomes Project is to maximize the public benefit of the data produced. NIH strongly endorses rapid release of genomic data and software as a general practice. The 1000 Genomes Project aims to release all Project data rapidly before publication. The Project data produced by the sequencing centers and the data-processing pipelines of the DCC are not supported by this FOA. This FOA supports the development of the methods that will be used to produce the various data types from the sequence reads or basic derived data types.
i. Methods and datasets: As awardees develop methods and analyze 1000 Genomes data, they may generate primary Project datasets, as well as secondary resource datasets that would be of use to other researchers. Examples of such resource datasets include simulated data, test datasets, and annotated validation data. These datasets and descriptions of all the methods developed would be useful to the research community when the methods are implemented in the 1000 Genomes production pipelines (generally by the DCC but possibly by other groups). Applicants should describe the schedule for methods and resource dataset sharing, the formats of the datasets, the documentation to be provided, and the mode of data sharing (e.g., mailing a disk, posting on a web site, or providing the data and methods descriptions to the DCC or other database).
ii. Software: Applications that propose to develop software must include a dissemination plan, with appropriate timelines. There is no particular prescribed license for software produced through awards supported through this FOA, although open-source software sharing is strongly encouraged. NHGRI has goals for software dissemination, and reviewers will be instructed to evaluate the dissemination plan relative to these goals:
1. The software, including the source code, should be freely available to the broad research community.
2. The terms of software availability should permit the commercialization of enhanced or customized versions of the software, and incorporation of the software or pieces of it into other software packages.
3. To preserve utility to the community, the software should be transferable so that another group could continue development if the original investigators were unwilling or unable to do so.
4. The terms of software availability should allow researchers to modify the source code and to share modifications with other colleagues. An awardee should be responsible for creating the original and subsequent "official" versions of a piece of software, and should provide a plan to manage the dissemination, adoption of improvements, or customizations of that software by others. This plan should include a method to distribute other user's contributions such as extensions, compatible modules, or plug-ins.
(b) Sharing Model Organisms: Regardless of the amount requested, all applications where the development of model organisms is anticipated are expected to include a description of a specific plan for sharing and distributing unique model organisms and related resources, or state appropriate reasons why such sharing is restricted or not possible. See Sharing Model Organisms Policy, and NIH Guide NOT-OD-04-042.
(c) Genome-Wide Association Studies (GWAS): Regardless of the amount requested, applicants seeking funding for a genome-wide association study are expected to provide a plan for submission of GWAS data to the NIH-designated GWAS data repository, or provide an appropriate explanation why submission to the repository is not possible. A genome-wide association study is defined as any study of genetic variation across the entire genome that is designed to identify genetic associations with observable traits (such as blood pressure or weight) or the presence or absence of a disease or condition. For further information see Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies, NIH Guide NOT-OD-07-088, and https://grants.nih.gov/grants/gwas/.
Section V. Application Review Information
1. Criteria (Update: Enhanced review criteria have been issued for the evaluation of research applications received for potential FY2010 funding and thereafter - see NOT-OD-09-025).
Only the review criteria described below will be considered in the review process.
2. Review and Selection Process
Applications that are complete and responsive to the FOA will be evaluated for scientific and technical merit by an appropriate peer review group convened by NHGRI and in accordance with NIH peer review procedures (http://grants1.nih.gov/grants/peer/), using the review criteria stated below.
As part of the scientific peer review, all applications will:
The following will be considered in making funding decisions:
goals of NIH supported research are to advance our understanding of biological
systems, to improve the control of disease, and to enhance health. In their
written critiques, reviewers will be asked to comment on each of the following
criteria in order to judge the likelihood that the proposed research will have
a substantial impact on the pursuit of these goals. Each of these criteria will
be addressed and considered in assigning the overall score, weighting them as
appropriate for each application. Note that an application does not need to be
strong in all categories to be judged likely to have major scientific impact
and thus deserve a meritorious priority score. For example, an investigator may
propose to carry out important work that by its nature is not innovative but is
essential to move a field forward.
Significance: Does this study address an important problem? If the aims of the application are achieved, how will scientific knowledge or clinical practice be advanced? What will be the effect of these studies on the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field? Will the proposed analyses be useful for a large part of the community of users of the dataset?
Approach: Are the conceptual or clinical framework, design, methods, and analyses adequately developed, well integrated, well reasoned, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics? If appropriate, are the approaches integrated with other analyses for the Project? Are the plans for sharing the methods, software, and any datasets adequate and appropriate for the Project?
Innovation: Is the project original and innovative? For example: Does the project challenge existing paradigms or clinical practice; address an innovative hypothesis or critical barrier to progress in the field? Does the project develop or employ novel concepts, approaches, methodologies, tools, or technologies for this area? Is the level of innovation appropriate for the role of the proposed analyses in the Project?
Investigators: Are the investigators appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers? Does the investigative team bring complementary and integrated expertise to the project (if applicable)? Do the investigators have experience in working cooperatively with others and sharing data and methods in a timely manner?
Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed studies benefit from unique features of the scientific environment, or subject populations, or employ useful collaborative arrangements? Is there evidence of institutional support?
Additional Review Criteria:
In addition to the above criteria, the following items will continue to be considered in the determination of scientific merit and the rating:
Protection of Human Subjects from Research Risk: The involvement of human subjects and protections from research risk relating to their participation in the proposed research will be assessed (see the Research Plan section on Human Subjects in the PHS 398 instructions).
Inclusion of Women, Minorities and Children in Research: The adequacy of plans to
include subjects from both genders, all racial and ethnic groups (and
subgroups), and children as appropriate for the scientific goals of the
research will be assessed. Plans for the recruitment and retention of subjects
will also be evaluated (see the Research Plan section on Human Subjects in the
PHS 398 instructions).
Care and Use of Vertebrate Animals in Research: If vertebrate animals are to be used in the project, the five points described in the Vertebrate Animals section of the Research Plan will be assessed.
Biohazards: If materials or procedures are proposed that are potentially hazardous to research personnel and/or the environment, determine if the proposed protection is adequate.
2.B. Additional Review Considerations
Budget: The reasonableness of the proposed budget and the requested period of support in relation to the proposed research. The priority score should not be affected by the evaluation of the budget.
2.C. Resource Sharing Plan(s)
When relevant, reviewers will be instructed to comment on the reasonableness of the following Resource Sharing Plans, or the rationale for not sharing the following types of resources. However, reviewers will not factor the proposed resource sharing plan(s) into the determination of scientific merit or priority score, unless noted otherwise in the FOA. Program staff within the IC will be responsible for monitoring the resource sharing.
All applications must include a plan for sharing research data. All investigators responding to this funding opportunity should include a description of how methods, datasets, and software will be shared, or explain why data sharing is not possible. However, rapid release of the methods, datasets, and software would benefit the scientific user community because of the scope of this community resource project.
Data Sharing Plans: For this FOA, the reasonableness of the plans for sharing methods, datasets, and software or the rationale for not sharing them will be assessed by the reviewers. Reviewers will factor the proposed data sharing plan into the determination of scientific merit and the priority score. The adequacy of the sharing plans will be considered by Program staff of the funding organization when making recommendations about funding applications. Program staff may negotiate modifications of the sharing plans with the awardee before recommending funding of an application. The final version of the sharing plans will become a condition of the award of the grant. The funding organization will be responsible for monitoring the data sharing policy.
3. Anticipated Announcement and Award
It is anticipated that applications will be reviewed late in 2009 and that awards will be made in the spring of 2010.
Section VI. Award Administration Information
1. Award Notices
After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons.
If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant. For details, applicants may refer to the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General.
formal notification in the form of a Notice of Award (NoA) will be
provided to the applicant organization. The NoA signed by the grants management
officer is the authorizing document. Once all administrative and programmatic
issues have been resolved, the NoA will be generated via email notification
from the awarding component to the grantee business official (designated in
item 12 on the Application Face Page). If a grantee is not email enabled, a
hard copy of the NoA will be mailed to the business official.
Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs. See Also Section IV.5. Funding Restrictions.
2. Administrative and National Policy Requirements
Samples: The
samples to be used by the 1000 Genomes Project will have been decided on by the
Project. They include many samples from both sexes, most racial groups,
and several ethnic groups, as well as some children (although subject age is
not scientifically relevant for this study). Awardees will analyze
publicly available data from anonymized subjects, so the research is not
considered to be on human subjects.
Intellectual property: A primary objective of the 1000 Genomes Project is to maximize the public benefit of the data produced. Accordingly, awardees should manage intellectual property (IP) and data in a way that achieves this goal. For the 1000 Genomes Project, awardees are expected to contribute to the generation of a large collection of data that will serve as a foundation for the scientific community to develop future diagnostics, therapeutics, and other medical applications. To achieve the objective of producing and broadly sharing the resources generated by the 1000 Genomes Project, applicants should develop a comprehensive IP and data management strategy that is consistent with the NIH Research Tools Policy (http://ott.od.nih.gov/policy/research_tool.html). Examples that applicants may wish to consider include the recommendations cited in NIH's Best Practices for the Licensing of Genomic Inventions (http://www.ott.nih.gov/policy/genomic_invention.html). Program staff may negotiate modifications of the IP management plan with the awardee before recommending funding of an application. The final version of the IP management plan will become part of the Terms and Conditions of the award.
NIH grant and cooperative agreement awards include the NIH Grants Policy
Statement as part of the Notice of Award. For these terms of award, see
the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards,
Subpart A: General (https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm)
and Part II Terms and Conditions of NIH Grant Awards, Subpart B: Terms and
Conditions for Specific Types of Grants, Grantees, and Activities (https://grants.nih.gov/archive/grants/policy/nihgps_2003/index.htm).
The following Terms and Conditions will be incorporated into the award statement and will be provided to the Principal Investigator as well as to the appropriate institutional official, at the time of award.
Cooperative Agreement Terms and Conditions of Award
The following special terms of award are in addition to, and not in lieu of, otherwise applicable OMB administrative guidelines, HHS grant administration regulations at 45 CFR Parts 74 and 92 (Part 92 is applicable when State and local Governments are eligible to apply), and other HHS, PHS, and NIH grant administration policies.
The administrative and funding instrument used for this program will be the cooperative agreement an "assistance" mechanism (rather than an "acquisition" mechanism), in which substantial NIH programmatic involvement with the awardees is anticipated during the performance of the activities. Under the cooperative agreement, the NIH purpose is to support and stimulate the recipients' activities by involvement in and otherwise working jointly with the award recipients in a partnership role; it is not to assume direction, prime responsibility, or a dominant role in the activities. Consistent with this concept, the dominant role and prime responsibility resides with the awardees for the project as a whole, although specific tasks and activities may be shared among the awardees and the NIH as defined below.
2. A.1. Principal Investigator Rights and Responsibilities
The Principal Investigator will have the primary responsibility for defining the details for the project within the guidelines of RFA-HG-09-002 and for performing the scientific activities. The P.I. will agree to accept close coordination, cooperation, and participation of NIH staff in those aspects of scientific and technical management of the project as described under "NIH Program Staff Responsibilities".
The P.I. of a 1000 Genomes data analysis research group will:
Awardees will retain custody of and
have primary rights to the data and software developed under these awards,
subject to Government rights of access consistent with current HHS, PHS, and
NIH policies.
2. A.2. NIH Responsibilities
The NIH Program Director is a scientist of the NHGRI extramural staff who will provide normal stewardship of the award and, in addition, will have substantial scientific and programmatic involvement during the conduct of this activity through technical assistance, advice, and coordination. However, the role of NIH staff will be to facilitate and not to direct the activities. It is anticipated that decisions in all activities will be reached by consensus of the 1000 Genomes Steering Committee and Analysis Group and that NIH staff will be given the opportunity to offer input to this process. The NIH Program Director will participate as a member of the Steering Committee and Analysis Group and will have one vote. The NIH Program Director will have the following substantial involvement:
2.A.3. Collaborative Responsibilities
The 1000 Genomes Steering Committee will continue to serve as the main governing board of the 1000 Genomes Consortium. It includes the co-chairs of the Project as well as the co-chairs of all the working groups, a representative from each sequencing center, and some additional members, including the NHGRI Program Director. Almost all calls of the Steering Committee are open to all Project participants. The 1000 Genomes Analysis Group includes all the participants in the Project working on data processing and analyses, as well as the NIH Program Director. The P.I. from an awarded cooperative agreement as well as his/her relevant staff may be added to the Analysis Group, depending on the needs of the Project; any awardee groups not part of the Analysis Group would still be expected to work closely with the Analysis Group. The Steering Committee and Analysis Group may add additional members. Other government staff may attend the Steering Committee and Analysis Group calls and meetings if their expertise is required for specific discussions.
To address particular issues, the Steering Committee and Analysis Group may establish groups as needed, which would include representatives from the grantees and the funding agencies, and possibly other experts. Each awardee P.I. will have one vote on the Analysis Group. Awardees will be required to accept and implement the common guidelines, procedures, and policies approved by the Steering Committee and the Analysis Group.
2.A.4. Arbitration Process
Any disagreements that may arise in scientific or programmatic matters (within the scope of the award) between award recipients and the NIH may be brought to arbitration. An Arbitration Panel composed of three members will be convened. It will have three members: a designee of the Steering Committee chosen without NIH staff voting, one NIH designee, and a third designee with expertise in the relevant area who is chosen by the other two; in the case of individual disagreement, the first member may be chosen by the individual awardee. This special arbitration procedure in no way affects the awardee's right to appeal an adverse action that is otherwise appealable in accordance with PHS regulations 42 CFR Part 50, Subpart D and HHS regulations 45 CFR Part 16.
3. Reporting
Awardees will be required to report progress on a regular basis to the Analysis Group, in a way that the Analysis Group decides on.
Awardees will be required to submit the Non-Competing Continuation Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.
A final progress report, invention statement, and Financial Status Report are required when an award is relinquished when a recipient changes institutions or when an award is terminated.
encourage your inquiries concerning this funding opportunity and welcome the
opportunity to answer questions from potential applicants. Inquiries may fall
into three areas: scientific/research, peer review, and financial or grants
management issues:
1. Scientific/Research Contacts:
Lisa D. Brooks, Ph.D.
5635 Fishers Lane, Suite 4076
Bethesda, MD 20892-9305
(301) 435-5544
2. Peer Review Contacts:
Rudy Pozzatti, Ph.D.
NHGRI Review Branch
5635 Fishers Lane
Suite 4076, MSC 9306
Bethesda, MD 20892-9306
(For courier service use Rockville, MD 20852)
3. Financial or Grants Management Contacts:
Ms. Cheryl Chick
5635 Fishers Lane, Suite 4076
Bethesda, MD 20892-9306
(301) 435-7858
Section VIII. Other Information
Required Federal Citations
Use of Animals in Research:
Recipients of PHS support for activities involving live, vertebrate animals must comply with PHS Policy on Humane Care and Use of Laboratory Animals (https://grants.nih.gov/grants/olaw/references/PHSPolicyLabAnimals.pdf) as mandated by the Health Research Extension Act of 1985 (https://grants.nih.gov/grants/olaw/references/hrea1985.htm), and the USDA Animal Welfare Regulations (http://www.nal.usda.gov/awic/legislat/usdaleg1.htm) as applicable.
Human Subjects Protection:
Federal regulations (45CFR46) require that applications and proposals involving human subjects must be evaluated with reference to the risks to the subjects, the adequacy of protection against these risks, the potential benefits of the research to the subjects and others, and the importance of the knowledge gained or to be gained (http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.htm).
Data and Safety Monitoring Plan:
Data and safety monitoring is required for all types of clinical trials, including physiologic toxicity and dose-finding studies (phase I); efficacy studies (Phase II); efficacy, effectiveness and comparative trials (Phase III). Monitoring should be commensurate with risk. The establishment of data and safety monitoring boards (DSMBs) is required for multi-site clinical trials involving interventions that entail potential risks to the participants (NIH Policy for Data and Safety Monitoring, NIH Guide for Grants and Contracts, https://grants.nih.gov/grants/guide/notice-files/not98-084.html).
Sharing Research Data:
Investigators submitting an NIH application seeking $500,000 or more in direct costs in any single year are expected to include a plan for data sharing or state why this is not possible (https://grants.nih.gov/grants/policy/data_sharing).
Investigators should seek guidance from their institutions, on issues related to institutional policies and local IRB rules, as well as local, State and Federal laws and regulations, including the Privacy Rule. Reviewers will consider the data sharing plan but will not factor the plan into the determination of the scientific merit or the priority score.
Policy for Genome-Wide Association Studies (GWAS):
NIH is interested in advancing genome-wide association studies (GWAS) to identify common genetic factors that influence health and disease through a centralized GWAS data repository. For the purposes of this policy, a genome-wide association study is defined as any study of genetic variation across the entire human genome that is designed to identify genetic associations with observable traits (such as blood pressure or weight), or the presence or absence of a disease or condition. All applications, regardless of the amount requested, proposing a genome-wide association study are expected to provide a plan for submission of GWAS data to the NIH-designated GWAS data repository, or provide an appropriate explanation why submission to the repository is not possible. Data repository management (submission and access) is governed by the Policy for Sharing of Data Obtained in NIH Supported or Conducted Genome-Wide Association Studies, NIH Guide NOT-OD-07-088. For additional information, see https://grants.nih.gov/grants/gwas/
to Research Data through the Freedom of Information Act:
The Office of Management and Budget (OMB) Circular A-110 has been revised to provide access to research data through the Freedom of Information Act (FOIA) under some circumstances. Data that are (1) first produced in a project that is supported in whole or in part with Federal funds and (2) cited publicly and officially by a Federal agency in support of an action that has the force and effect of law (i.e., a regulation) may be accessed through FOIA. It is important for applicants to understand the basic scope of this amendment. NIH has provided guidance at https://grants.nih.gov/grants/policy/a110/a110_guidance_dec1999.htm. Applicants may wish to place data collected under this funding opportunity in a public archive, which can provide protections for the data and manage the distribution for an indefinite period of time. If so, the application should include a description of the archiving plan in the study design and include information about this in the budget justification section of the application. In addition, applicants should think about how to structure informed consent statements and other human subjects procedures given the potential for wider use of data collected under this award.
Sharing of Model Organisms:
NIH is committed to support efforts that encourage sharing of important research resources including the sharing of model organisms for biomedical research (see https://grants.nih.gov/grants/policy/model_organism/index.htm). At the same time the NIH recognizes the rights of grantees and contractors to elect and retain title to subject inventions developed with Federal funding pursuant to the Bayh Dole Act (see the NIH Grants Policy Statement https://grants.nih.gov/archive/archive/grants/policy/nihgps_2003/index.htm). All investigators submitting an NIH application or contract proposal, beginning with the October 1, 2004 receipt date, are expected to include in the application/proposal a description of a specific plan for sharing and distributing unique model organism research resources generated using NIH funding or state why such sharing is restricted or not possible. This will permit other researchers to benefit from the resources developed with public funding. The inclusion of a model organism sharing plan is not subject to a cost threshold in any year and is expected to be included in all applications where the development of model organisms is anticipated.
Inclusion of Women And Minorities in Clinical Research:
It is the policy of the NIH that women and members of minority groups and their sub-populations must be included in all NIH-supported clinical research projects unless a clear and compelling justification is provided indicating that inclusion is inappropriate with respect to the health of the subjects or the purpose of the research. This policy results from the NIH Revitalization Act of 1993 (Section 492B of Public Law 103-43). All investigators proposing clinical research should read the "NIH Guidelines for Inclusion of Women and Minorities as Subjects in Clinical Research (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-001.html); a complete copy of the updated Guidelines is available at https://grants.nih.gov/grants/funding/women_min/guidelines_amended_10_2001.htm. The amended policy incorporates: the use of an NIH definition of clinical research; updated racial and ethnic categories in compliance with the new OMB standards; clarification of language governing NIH-defined Phase III clinical trials consistent with the new PHS Form 398; and updated roles and responsibilities of NIH staff and the extramural community. The policy continues to require for all NIH-defined Phase III clinical trials that: a) all applications or proposals and/or protocols must provide a description of plans to conduct analyses, as appropriate, to address differences by sex/gender and/or racial/ethnic groups, including subgroups if applicable; and b) investigators must report annual accrual and progress in conducting analyses, as appropriate, by sex/gender and/or racial/ethnic group differences.
Inclusion of Children as Participants in Clinical Research:
The NIH maintains a policy that children (i.e., individuals under the age of 21) must be included in all clinical research, conducted or supported by the NIH, unless there are scientific and ethical reasons not to include them.
All investigators proposing research involving human subjects should read the "NIH Policy and Guidelines" on the inclusion of children as participants in research involving human subjects (https://grants.nih.gov/grants/funding/children/children.htm).
Required Education on the Protection of Human Subject Participants:
NIH policy requires education on the protection of human subject participants for all investigators submitting NIH applications for research involving human subjects and individuals designated as key personnel. The policy is available at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-00-039.html.
Human Embryonic Stem Cells (hESC):
Criteria for federal funding of research on hESCs can be found at http://stemcells.nih.gov/index.asp and at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-02-005.html. Only research using hESC lines that are registered in the NIH Human Embryonic Stem Cell Registry will be eligible for Federal funding (http://escr.nih.gov). It is the responsibility of the applicant to provide in the project description and elsewhere in the application as appropriate, the official NIH identifier(s) for the hESC line(s) to be used in the proposed research. Applications that do not provide this information will be returned without review.
NIH Public Access Policy Requirement:
In accordance with the NIH Public Access Policy (https://grants.nih.gov/grants/guide/notice-files/NOT-OD-08-033.html) investigators must submit or have submitted for them their final, peer-reviewed manuscripts that arise from NIH funds and are accepted for publication as of April 7, 2008 to PubMed Central (http://www.pubmedcentral.nih.gov/), to be made publicly available no later than 12 months after publication. As of May 27, 2008, investigators must include the PubMed Central reference number when citing an article in NIH applications, proposals, and progress reports that fall under the policy, and was authored or co-authored by the investigator or arose from the investigator's NIH award. For more information, see the Public Access webpage at http://publicaccess.nih.gov/.
for Privacy of Individually Identifiable Health Information:
The Department of Health and Human Services (DHHS) issued final modification to the "Standards for Privacy of Individually Identifiable Health Information", the "Privacy Rule", on August 14, 2002. The Privacy Rule is a federal regulation under the Health Insurance Portability and Accountability Act (HIPAA) of 1996 that governs the protection of individually identifiable health information, and is administered and enforced by the DHHS Office for Civil Rights (OCR).
Decisions about applicability and implementation of the Privacy Rule reside with the researcher and his/her institution. The OCR website (http://www.hhs.gov/ocr/) provides information on the Privacy Rule, including a complete Regulation Text and a set of decision tools on "Am I a covered entity?" Information on the impact of the HIPAA Privacy Rule on NIH processes involving the review, funding, and progress monitoring of grants, cooperative agreements, and research contracts can be found at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-03-025.html.
URLs in NIH Grant Applications or Appendices:
All applications and proposals for NIH funding must be self-contained within specified page limitations. For publications listed in the appendix and/or Progress report, internet addresses (URLs) must be used for publicly accessible on-line journal articles. Unless otherwise specified in this solicitation, Internet addresses (URLs) should not be used to provide any other information necessary for the review because reviewers are under no obligation to view the Internet sites. Furthermore, we caution reviewers that their anonymity may be compromised when they directly access an Internet site.
People 2010:
The Public Health Service (PHS) is committed to achieving the health promotion and disease prevention objectives of "Healthy People 2010," a PHS-led national activity for setting priority areas. This FOA is related to one or more of the priority areas. Potential applicants may obtain a copy of "Healthy People 2010" at http://www.health.gov/healthypeople.
Authority and Regulations: This program is described in the Catalog of Federal Domestic Assistance at http://www.cfda.gov/ and is not subject to the intergovernmental review requirements of Executive Order 12372. Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR 52 and 45 CFR Parts 74 and 92. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement. The NIH Grants Policy Statement can be found at https://grants.nih.gov/grants/policy/policy.htm.
The PHS strongly encourages all grant recipients to provide a smoke-free workplace and discourage the use of all tobacco products. In addition, Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in certain facilities (or in some cases, any portion of a facility) in which regular or routine education, library, day care, health care, or early childhood development services are provided to children. This is consistent with the PHS mission to protect and advance the physical and mental health of the American people.
Loan Repayment Programs:
NIH encourages applications for educational loan repayment from qualified health professionals who have made a commitment to pursue a research career involving clinical, pediatric, contraception, infertility, and health disparities related areas. The LRP is an important component of NIH's efforts to recruit and retain the next generation of researchers by providing the means for developing a research career unfettered by the burden of student loan debt. Note that an NIH grant is not required for eligibility and concurrent career award and LRP applications are encouraged. The periods of career award and LRP award may overlap providing the LRP recipient with the required commitment of time and effort, as LRP awardees must commit at least 50% of their time (at least 20 hours per week based on a 40 hour week) for two years to the research. For further information, please see: http://www.lrp.nih.gov.
Weekly TOC for this Announcement
NIH Funding Opportunities and Notices
Office of Extramural
Research (OER)
National Institutes of Health (NIH)
9000 Rockville Pike
Bethesda, Maryland 20892
Department of Health
and Human Services (HHS)
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.

subset: commoncrawl


text:
Pirates edged by Cubs, fall to second place in Central
Pittsburgh hits three straight homers, but bullpen can't hold lead
PITTSBURGH -- The Pirates' hex on Friday the 13th continued, as the Cubs defeated Pittsburgh, 5-4, in front of 35,962 fans at PNC Park.
According to the Elias Sports Bureau, the Pirates have lost 11 consecutive games on Friday the 13th. The loss also snapped a four-game Pirates winning streak and pushed Pittsburgh to a game back in the National League Central, as the Cardinals beat the Mariners in 10 innings. The Bucs hold a 2 1/2-game lead over the Reds for the top NL Wild Card spot.
Right-hander Charlie Morton started for the Pirates. There was some doubt about whether Morton would be able to pitch after he left in the second inning last Sunday at St. Louis because of pain from plantar fasciitis in his left heel; however, he tossed five innings and allowed three runs on four hits to finish with a no-decision.
"Morton had to grind one out tonight," Pirates manager Clint Hurdle said. "I think he went out there with intent and purpose; the sinker didn't play consistently. The one inning he left three balls up and left-handers squared them up. But he battled."
"They swung the bat, they put a lot of good swings on the ball," Morton said. "They are professionals. You don't make a good pitch, and even when you do, sometimes good hitters are going to hit it. It doesn't matter who you are facing, they're pros."
Pirates reliever Jason Grilli was tagged with the loss after allowing a go-ahead two-run homer to Anthony Rizzo in the seventh to fall to 0-2.
"Grilli is so close, and we need to keep him in play," Hurdle said. "It's not like we try to pitch him every other day. Three days down at the most to get him back in there to get him consistent work, and this is another time where there's two outs and he's just one pitch away from getting out of an inning.
"We weren't able to put away [Luis] Valbuena, and that one ended up hurting. The pitch to Rizzo, and it ended up out of the park. We've got to keep getting him out there on a somewhat consistent basis if we want to get him better. He's not going to get better not pitching."
Cubs right-hander Jake Arrieta pitched five-plus innings and allowed four runs, three earned, on six hits. Right-hander Carlos Villanueva picked up the win in relief to up his record to 6-8.
The Cubs scratched out a run off Morton in the top of the second inning. Nate Schierholtz drew a leadoff walk and was sacrificed to second base by Ryan Sweeney. Brian Bogusevic singled to left, putting runners on first and third. Darwin Barney bounced into a fielder's choice to score Schierholtz and give the Cubs a 1-0 lead.
Morton was touched up for two more runs in the fourth inning. With two outs and Dioner Navarro on base, Bogusevic smacked a two-run home run to give the Cubs a 3-0 lead.
The Pirates broke through against Arrieta in the bottom of the fourth inning. Pedro Alvarez had gone 15 games without a home run since taking over the NL lead with his 32nd blast on Aug. 27. With two outs, Alvarez smacked an inside-the-park home run off the fence in right-center. Russell Martin followed with his 14th home run of the season. Garrett Jones then stroked his 14th home run to tie the game at 3.
"The first one to Alvarez was a good cutter middle-in, and somehow he was able to put the barrel on it," Arrieta said. "It sounded good, and as high as he hit it, I didn't think there was a chance it was going to get out. Some fan interference there, a close call, but nobody said anything of it.
"Russell coming up, the second home run, he's a veteran hitter and I wanted to execute down and away, and I left it up and he did the damage there," Arrieta said. "Garrett Jones, I started him off with a really good breaking ball, and I threw another one and left it a little too much in the middle of the plate, and he did a good job putting a good swing on it."
"You know, you don't see it all the time, and when you see it, it usually happens in a hurry," Hurdle said. "Balls were up and elevated, and our guys put good swings on them."
It was the first time the Pirates had hit three consecutive home runs in one inning since Aug. 20, 2003, at St. Louis, when Jason Kendall, Brian Giles and Reggie Sanders accomplished the feat. The last time it happened for the Pirates at home was July 6, 1955, against Brooklyn, when Jerry Lynch, Frank Thomas and Dale Long homered.
After Andrew McCutchen doubled to lead off the sixth inning, Arrieta was replaced by lefty Brooks Raley. With one out, Alvarez reached base on an error by Raley trying to cover first base, allowing McCutchen to race home and give the Pirates a 4-3 lead.
The Cubs came back against Grilli. Following a two-out walk to Valbuena, Rizzo crushed his 22nd home run of the season to give Chicago a 5-4 lead.
"He threw me a slider," Rizzo explained. "He's an All-Star closer coming in the seventh for this team. That says a lot about the Pirates. He was down and in, and I just put a good swing on it and tried not to do too much."
Cubs right-hander Kevin Gregg pitched a scoreless ninth inning to pick up his 32nd save.


text:
C82 - Electric Ranges
Possible Solutions
Turn off the oven if it is operating.
- The surface cooking area has overheated and the automatic shutoff was activated.
- Wait 5 minutes, for it to cool down, then turn the cooktop back on.
- Verify cooktop operation.
Reset power to the product:
- Power unit down by turning off the circuit breaker(s) for one (1) minute.
- Power unit up by turning on the circuit breaker(s).
- Monitor the cooktop for one (1) minute to ensure the error code does not display again.
- Verify cooktop operation.
Still need help? Call or schedule service.
You may need assistance from a qualified technician. Call 1-800-JENN-AIR (536-6247) or click below to schedule an appointment.


text:
3DS Ambassador Program
Play your 3DS Ambassador Game Boy Advance games in original resolution
1UP has issued a timely PSA on how to play Virtual Console games on the 3DS at their original resolution, rather than smeared across the larger screen. It's pretty easy – after launching the game from the channels menu, just hold down start or select until the black boot-up screen appears. Last week, Nintendo finally […]
3DS Ambassador Program headlines
3DS Ambassador Game Boy Advance games due Friday
Early adopters who remembered to register for Nintendo's 3DS Ambassador scheme, introduced to compensate for a price cut in August, will finally see the Game Boy Advance portion of the promised goods this week. According to SpotPass notifications, as noted by ONM, F-Zero Maximum Velocity, Super Mario Advance 3: Yoshi's Island, The Legend of Zelda: […]
Nintendo: 3DS Ambassador Program games to release "before the end of December"
Nintendo has confirmed that its Ambassador games are still coming this year to early adopters of 3DS. Rumors yesterday, stemming from Nintendo Spain (thanks Mark) had the games being delayed into next year. However, when contacted by ONM, a Nintendo spokesperson told the magazine the Game Boy Advance games "will be available before the end […]
3DS Ambassador Program kicks off in Europe
Nintendo's begun the 3DS Ambassador Program in Europe, enabling owners who bought the handheld before last month's price-cut to get ten free game downloads.
US: 3DS Ambassador Program detailed
Nintendo of America has unveiled the last NES titles of the 3DS Ambassador Program, and detailed how to get hold of your free swag.
Australia: Last chance entry to 3DS Ambassador Program
If you purchased a 3DS before the cut-off date but failed to register for the Ambassador Program and attendant free games, Nintendo of Australia is offering one last chance.
3DS Ambassador Program registration still open in Europe
If you failed to get on board the 3DS Ambassador Program before August 12, there's still hope.
Nintendo details 3DS Ambassador Program in scrolling text form
Nintendo's released a video of how the company's Ambassador program will work in the UK following the bombshell announcement a couple of weeks ago of a worldwide 3DS price-cut that takes affect from this Friday. Nothing that hasn't been detailed before, but now you can get it in video form. It's below the break.Thanks, Kotaku.
Two more GBA titles named for 3DS Ambassador Program
Super Mario Advance 4: Super Mario Bros. 3 and Kirby & the Amazing Mirror have been added to the Gameboy Advance line up of the 3DS Ambassador program.
Games part of the 3DS Ambassador Program getting multiplayer upgrade
Nintendo has said the games which are part of the Ambassador Program outlined this week during its financials, will include additional features and upgrades.
3DS Ambassador Program latest
Play your 3DS Ambassador Game Boy Advance games in original resolution
Nintendo: 3DS Ambassador Program games to release "before the end of December"
Nintendo details 3DS Ambassador Program in scrolling text form
Games part of the 3DS Ambassador Program getting multiplayer upgrade


text:
Exciting opportunity for an experienced Neonatal Nurse Practitioner to practice at The Woman's Hospital of Texas in Houston, TX.
Houston is the largest city in the State of Texas offering a thriving economy, affordable housing market, and excellent public and private schools. Whether you prefer family-friendly communities, suburban living or high-rise living, there are many options that will suit any lifestyle. Another plus is the temperate climate! Residents can enjoy golf and other outdoor activities nearly all year long. There is also no state income tax in Texas.
Our clinicians enjoy a competitive compensation package with many locations offering sign on bonuses, relocation and tuition reimbursement.
*Our benefits include:
*These benefits are for full time employees, employees in other types of employment classifications may be eligible for some of these benefits.
About MEDNAX
With a 40+ year record of success, MEDNAX has grown from a single medical practice to a trusted health solutions partner. As part of our national medical group, we give you the tools you need to build the career you want, and the flexibility to adapt as your personal needs and professional interests change.
We invite you to grow with us and help shape the future of health care.
MEDNAX is an Equal Opportunity Employer
All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.


text:
A recent study published in the online edition of Pediatrics confirms what I see in my practice. According to this study, the incidence of positional plagiocephaly (head flattening) has increased and is now estimated to occur in about 47 percent of babies between the ages of 7 weeks and 12 weeks.
The recommendation to have babies change from the tummy sleeping position to back sleeping was made in 1992. Since that time there has been more than a 50 percent decline in the incidence of SIDS (sudden infant death syndrome). But both doctors and parents have noticed that infants have sometimes developed flattened or misshapen heads from spending so much time being on their backs during those first few months of life.
This study was conducted in Canada among 440 healthy infants. In 1999, Canada, like the U.S., began recommending back sleeping for babies. Canadian doctors had also reported that they were seeing more plagiocephaly among infants.
The authors found that 205 infants in the study had some form of plagiocephaly, with 78 percent being classified as mild, 19 percent moderate and 3 percent severe. Interestingly, there was a greater incidence (63 percent) of a babies having flattening on the right side of their heads.
Latest Business
Flattening of the head, either on the back or sides is most often due to the fact that a baby is not getting enough "tummy time." Although babies should sleep on their back, there are many opportunities throughout a day for a baby to be prone on a blanket while awake, or to spend time being snuggled upright over a parent's shoulder or in the parent's arms. Limiting time spent in a car seat or a bouncy chair will also help prevent flattening.
Most importantly, before discharging their baby from the hospital I tell parents that tummy time needs to begin right away. It does seem that some babies have "in utero" positional preference for head turning, and this needs to be addressed early on. Think of a baby being just like us: Don't you like to sleep on one side or another? By rotating the direction the baby lies in the crib you can help promote head turning and prevent flattening.
Lastly, most cases of plagiocephaly are reversible. Just put tummy time on your daily new parent to-do list.
Submit questions at http://www.kidsdr.com.


text:
Hello there!
Looking at D&D at Wikia I came from Wikipedia to D&D Wiki. Now I am working towards the integration of the imported material from D&D Wiki. For more details, don't hesitate to have a look at DnDWiki:Introduction.
In the past I have also been active at Forgotten Realms Wiki.
To do[edit | edit source]
...given enough time. Help appreciated, of course.
- Adapt main page
- Care about guidelines for Canon
- Care about navigation pages (especially navigation page of navigation pages)
- Merge miniature stubs into list - done
- Adapt DnDWiki!
- Missing redirects for miniatures
- Work on more complete miniature lists
- Overhaul Dave Arneson according to current Wikipedia article
- Sources for Canon:Aerdrie Faenya
- Birthright publication articles
- Establish relationships with other wikis.
- Put link back in at Wikipedia!
- Care about sources for Birthright articles.
- Expand campaign setting stubs with the help of Wikipedia.
- Recreate userboxes?
- Work on categories (especially Uncategorized pages). - Done as far as I can of now.
- Have a look at Special Materials formatting
- Care about links in SRD:..., possibly after merge discussion is decided.
Community content is available under CC-BY-SA unless otherwise noted.


text:
The Chattahoochee River begins as a spring in the fittingly name "Chattahoochee Gap," little more than a trickle of water at 3200 feet. Over the first 100 miles the river falls almost 2400 feet, forms a major Southeast lake (Lanier) and provides water for millions of Georgians.
County: White County
About North Georgia
Georgia Imix
[American Indians] [Biography] [Parks ] [Attractions ] [Naturally] [Weather] [Railroads] [Rivers]
[Mountains] [Roads] [Feature Articles] [Previous Issues] [Facts] [Food]
[Giving Back] [Voices from the Past] [Poetry Corner] [Photography]
[Lodging] [About Us] [Bookstore ] [Events ] [Events by month ] [Letters ] [Help ] [Kudos ] [Randy's Corner]
Other Places: Today in Georgia History : Today in The Civil War : Georgia Attractions : Georgia Hiking : Chattanooga
Golden Ink Internet Solutions


text:
Hawaii classic car rentals
Hire a classic car company to rent an old rolls royce or other classic auto models for rental available. Prices start at about 200 per hour. We must drive them, client not allowed due to insurance.
Classic Car Rentals
for commercial or corporate events you may also call us at 1-800-232-6874 ext 7 (commercial only)
Home: All Products-Services
(and similar) |
Classic Car Rentals
(in other states)
Request Free Quotes: Hawaii Classic Car Rentals
Pick the nearest city below
Honolulu HI
Classic Car Rentals
Oahu HI
Classic Car Rentals
Approximate prices:
CLASSIC CARS are Chauffer Driven ONLY. Typically Vintage Rolls Royce 200-275 per hour and about 1000-1400 per day, Vintage Classic Mercedes 175-250 per hour and about 1000 per day, Ventage Model A 250-300 per hour and 1000-1500 per day, Others include Bentley 300 per hour, Escalades 200 per hour, H2 Hummer 200-250 per hour, Most more modern vehicles are between 150-250 per hour.
Free quotes from
Hawaii Classic Car Rentals!
List your business here
All Time Favorites
One Source for All Your Event Planning Needs © 2002-2020 All Time Favorites Inc.
50000 vendors across the USA and Canada
PO BOX 201325 Minneapolis MN 55420
All Time Favorites - Complete Event Planning Resources


text:
[ Source: openttd ]
Package: openttd-data (1.9.3-1build2) [universe]
Links for openttd-data
Ubuntu Resources:
Download Source Package openttd:
Please consider filing a bug or asking a question via Launchpad before contacting the maintainer directly.
Original Maintainers (usually from Debian):
- Matthijs Kooijman
- Jordi Mallach
It should generally not be necessary for users to contact the original maintainer.
External Resources:
- Homepage [www.openttd.org]
Similar packages:
common data files for the OpenTTD game
Download openttd-data
|Package Size
|Installed Size
|2,446.2 kB
|10,206.0 kB
|[list of files]


text:
Born: 1927, Kovno, Lithuania
Describes massacre in Kovno's Ninth Fort, near the Kovno ghetto [Interview: 1990]
Abraham came from a wealthy family that was ordered into the Kovno ghetto after the Germans occupied Lithuania in 1941. Abraham's mother urged his father to flee, but he returned for them. Begging for mercy, he was able to save them from a massacre in the Ninth Fort, one of several forts around Kovno. Abraham and his father survived internment in five camps before they were finally liberated in the Theresienstadt ghetto. Abe's mother perished at the Stutthof camp.
Copyright © United States Holocaust Memorial Museum, Washington, DC